STRATA Skin Sciences Inc (SSKN) - Cash Flow Conversion Efficiency
Based on the latest financial reports, STRATA Skin Sciences Inc (SSKN) has a cash flow conversion efficiency ratio of -0.082x as of December 2025. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow ($-239.00K) by net assets ($2.91 Million). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations. See SSKN equity financing ratio to measure how much of total assets are equity-financed.
STRATA Skin Sciences Inc - Cash Flow Conversion Efficiency Trend (2003–2025)
This chart illustrates how STRATA Skin Sciences Inc's cash flow conversion efficiency has evolved over time, based on yearly financial data. Check how high is STRATA Skin Sciences Inc's earnings quality to evaluate the quality of earnings relative to operating cash generation.
STRATA Skin Sciences Inc Competitors by Cash Flow Conversion Efficiency
The table below lists competitors of STRATA Skin Sciences Inc ranked by their cash flow conversion efficiency.
| Company | Cash Flow Conversion Efficiency |
|---|---|
|
RED LAKE GOLD INC.
F:P11A
|
-1.043x |
|
Futura Medical
LSE:FUM
|
-0.940x |
|
Vestand Inc.
NASDAQ:VSTD
|
-0.192x |
|
XLMedia PLC
LSE:XLM
|
-0.008x |
|
FAT Brands Inc
NASDAQ:FATBW
|
0.050x |
|
Chordate Medical Holding AB
ST:CMH
|
-0.514x |
|
Ukrproduct Group
LSE:UKR
|
0.310x |
|
Adomos SA
PA:ALADO
|
-0.008x |
Annual Cash Flow Conversion Efficiency for STRATA Skin Sciences Inc (2003–2025)
The table below shows the annual cash flow conversion efficiency of STRATA Skin Sciences Inc from 2003 to 2025. For the full company profile with market capitalisation and key ratios, see STRATA Skin Sciences Inc (SSKN) total market value.
| Year | Net Assets | Operating Cash Flow | Cash Flow Conversion Efficiency | Change |
|---|---|---|---|---|
| 2025-12-31 | $2.91 Million | $-2.79 Million | -0.961x | -2641.00% |
| 2024-12-31 | $4.97 Million | $188.00K | 0.038x | +192.44% |
| 2023-12-31 | $12.69 Million | $-519.00K | -0.041x | +19.41% |
| 2022-12-31 | $21.83 Million | $-1.11 Million | -0.051x | -185.53% |
| 2021-12-31 | $25.41 Million | $1.51 Million | 0.059x | -26.70% |
| 2020-12-31 | $25.89 Million | $2.10 Million | 0.081x | +4.06% |
| 2019-12-31 | $28.65 Million | $2.23 Million | 0.078x | -16.06% |
| 2018-12-31 | $31.25 Million | $2.90 Million | 0.093x | -50.20% |
| 2017-12-31 | $22.25 Million | $4.14 Million | 0.186x | +750.73% |
| 2016-12-31 | $14.72 Million | $322.00K | 0.022x | +105.34% |
| 2015-12-31 | $16.09 Million | $-6.58 Million | -0.409x | +71.62% |
| 2014-12-31 | $12.28 Million | $-17.71 Million | -1.443x | +38.35% |
| 2013-12-31 | $8.30 Million | $-19.41 Million | -2.340x | -70.12% |
| 2012-12-31 | $13.98 Million | $-19.22 Million | -1.376x | -134.86% |
| 2011-12-31 | $29.81 Million | $-17.46 Million | -0.586x | +1.04% |
| 2010-12-31 | $31.80 Million | $-18.82 Million | -0.592x | -3.70% |
| 2009-12-31 | $30.32 Million | $-17.30 Million | -0.571x | +46.85% |
| 2008-12-31 | $15.09 Million | $-16.20 Million | -1.074x | -101.89% |
| 2007-12-31 | $20.77 Million | $-11.05 Million | -0.532x | -11.79% |
| 2006-12-31 | $21.31 Million | $-10.14 Million | -0.476x | -48.05% |
| 2005-12-31 | $18.25 Million | $-5.87 Million | -0.321x | -137.23% |
| 2004-12-31 | $-3.55 Million | $-3.06 Million | 0.863x | -88.93% |
| 2003-12-31 | $-218.00K | $-1.70 Million | 7.798x | -- |
About STRATA Skin Sciences Inc
STRATA Skin Sciences, Inc., a medical technology company, develops, commercializes, and markets products for the treatment of dermatologic conditions in the United States, China, Europe, the Middle East, Asia, Australia, South Africa, and Central and South America. It operates through Dermatology Recurring Procedures and Dermatology Procedures Equipment segments. The company offers XTRAC excimer … Read more